LEVISTA 1

LEVISTA

Generic: LevetiracetamAntiepileptic
Product information at a glance
Available strengths
250 mg500 mg
Dosage form
Film-coated tablet, Solution
Pack sizes
Each box contains 3x10 tablets in Alu-PVC blister.Each box contains 2x10 tablets in Alu-PVC blister.Each bottle contains 100 ml of oral solution.

Strengths, dosage forms and pack sizes are taken from the product composition and packing information below.

Composition

  • Levista™ 250 Tablet: Each film coated tablet contains Levetiracetam USP 250 mg.
  • Levista™ 500 Tablet: Each film coated tablet contains Levetiracetam USP 500 mg.
  • Levista™ 100 ml Oral Solution: Each 5 ml solution contains Levetiracetam USP 500 mg.

Indications

Levista™ (tablet and oral solution) is indicated as adjunctive therapy in the treatment of:

  • Partial onset seizures in patients one month of age and older with epilepsy
  • Myoclonic seizures in patients 12 years of age and older with juvenile myoclonic epilepsy
  • Primary generalized tonic-clonic seizures in patients 6 years of age and older with idiopathic generalized epilepsy

Presentation & packing

  • Levista™ 250 Tablet: Each box contains 3x10 tablets in Alu-PVC blister.
  • Levista™ 500 Tablet: Each box contains 2x10 tablets in Alu-PVC blister.
  • Levista™ 100 ml Oral Solution: Each bottle contains 100 ml of oral solution.

Leaflet & prescribing information

Distributor enquiry

Speak to the NAAFCO Pharma export and distribution team about supply, pack sizes and availability of LEVISTA.

Related Products

NAAFCO Logo

Wellness through Innovation